This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Pharmacokinetic Study of MIN-101 in Healthy Subjec...
Clinical trial

Pharmacokinetic Study of MIN-101 in Healthy Subjects

Read time: 1 mins
Last updated:3rd Sep 2014

The aim of the study is to assess how MIN-101 is taken up by the body when given in different amounts and in different formulations. The drug will be given as a single dose in Part 1 of the study and during Part 2 of the study as multiple dose, once daily for 7 days. The ultimate aim is to find an optimal formulation which can be developed as a once daily dose for the treatment of schizophrenia.

Category Value
Study start date 2014-09-03

View full details